Thrombocytosis has a negative prognostic value in lung cancer

Anticancer Research

Volumn 33, Issue 4, 2013, Pages 1725-1730

  Maráz, Anikó ^a   Furák, József ^b   Varga, Zoltán ^a   Kahán, Zsuzsanna ^a   Tiszlavicz, László ^a   Hideghéty, Katalin ^a  

^a UNIVERSITY OF SZEGED   (Hungary)

^b UNIVERSITY OF SZEGED   (Hungary)

Author keywords

Lung cancer; Prognosis; Smoking; Thrombocytosis

Indexed keywords

ADULT; AGED; ARTICLE; CANCER PROGNOSIS; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE DURATION; FEMALE; HISTOLOGY; HUMAN; HUMAN TISSUE; LUNG CANCER; LUNG RESECTION; LUNG SQUAMOUS CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PERIOPERATIVE PERIOD; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SMOKING HABIT; THROMBOCYTE COUNT; THROMBOCYTOSIS;

ADENOCARCINOMA; ADULT; AGED; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SQUAMOUS CELL; FEMALE; FOLLOW-UP STUDIES; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; RETROSPECTIVE STUDIES; SMOKING; SURVIVAL RATE; THROMBOCYTOSIS;

EID: 84876767847     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Mountain CF: Revision in the International System for Staging Lung Cancer. Chest 111: 1710-17, 1997. (Pubitemid 27260107)
2. Hung JJ, Wang CY, Huang MH, Huang BS, Hsu WH and Wu YC: Prognostic factors in resected stage I non-small cell lung cancer with a diameter of 3 cm or less: Visceral pleural invasion did not influence overall and disease-free-survival. J Thorac Cardiovasc Surg 134: 638-643, 2007.
3. Kobayashi N, Toyooka S, Soh J, Ichimura K, Yanai H, Suehisa H, Ichihara S, Yamane M, Aoe M, Sano Y and Date H: Risk factors for recurrence and unfavorable prognosis in patients with stage I non-small cell lung cancer and a tumor diameter of 20 mm or less. J Thorac Oncol 2: 808-812, 2007. (Pubitemid 47361021)
4. Nakamura H, Haruki T, Adachi Y, Fujioka S, Miwa K and Taniguchi Y: Smoking affects prognosis after lung cancer surgery. Surg Today 38: 227-231, 2008. (Pubitemid 351328105)
5. Yoshino I, Kawano D, Oba T, Yamazaki K, Kometani T and Maehara Y: Smoking status as a prognostic factor in patients with stage I pulmonary adenocarcinoma. Ann Thorac Surg 81: 1189-1193, 2006.
6. Toh CK, Wong EH, Lim WT, Leong SS, Fong KW, Wee J and Tan EH: The impact of smoking status on the behaviour and survival outcome of patients with advanced non-small cell lung cancer. Chest 126: 1750-1756, 2004. (Pubitemid 39643975)
7. Hernandez E, Donohue KA, Anderson L, Heller PB and Stehman FB: The significance of thrombocytosis in patients with locally advanced cervical carcinoma: A Gynecologic Oncology Group Study. Gynecol Oncol 78: 137-142, 2000. (Pubitemid 30650343)
8. O'Keefe SC, Marshall FF, Issa MM, Harmon MP and Petros JA: Thrombocytosis is associated with significant increase in the cancer specific death rate after radical nephrectomy. J Urol 168: 1378-1380, 2002. (Pubitemid 35034126)
9. Shimada H, Ophira G, Okazumi S, Matsubara H, Nabeya Y, Hayashi H, Takeda A, Gunji Y and Ochiai T: Thrombocytosis associated with poor prognosis in patients with esophageal carcinoma. J Am Coll Surg 198: 737-41, 2004. (Pubitemid 38542902)
10. Ikeda M, Furukawa H, Imamura H, Shimizu J, Ishida H, Masutani S, Tatsuta M and Satomi T: Poor prognosis associated with thrombocytosis in patients with gastric cancer. Ann Surg Oncol 9: 287-91, 2002. (Pubitemid 34298634)
11. Verheul HMW, Hoekman K and Lupu F: Platelet and coagulation activation with vascular endothelial growth factor generation in soft tissue sarcomas. Clin Cancer Res 6: 166-171, 2000. (Pubitemid 30064990)
12. Pedersen LM and Milman N: Prognostic significance of thrombocytosis in patients with primary lung cancer. Eur Respir J 9: 1826-1830, 1996. (Pubitemid 26294751)
13. Hamilton W, Peters TJ, Round A and Sharp D: What are the clinical features of lung cancer before the diagnosis is made? A population based case-control study. Thorax 60: 1059-1065, 2005. (Pubitemid 41705477)
14. Aoe K, Hiraki A, Ueoka H, Kiura K, Tabata M, Tanaka M and Tanimoto M: Thrombocytosis as a useful prognostic indicator in patients with lung cancer. Respiration 71: 170, 2004.
15. Kotsori AA, Vaslamatzis MM and Alexopoulos CG: Thrombo-cytosis in primary lung cancer. Hosp Chron 1: 32-37, 2006.
16. Tomita M, Shimizu T, Hara M, Ayabe T, Matsuzaki Y and Onitsuka T: Preoperative leukocytosis, anemia and thrombocytosis are associated with poor survival in non-small cell lung cancer. Anticancer Res 29: 2687-90, 2009.
17. Holgersson G, Sandelin M, Hoye E, Bergström S, Henriksson R, Ekman S, Nyman J, Helsing M, Friesland S, Holgersson M, Lundström KL, Janson C, Birath E, Mörth C, Blystad T, Ewers SB, Löden B and Bergqvist M: Swedish lung cancer radiation study group: the prognostic value of anaemia, thrombocytosis and leukocytosis at time of diagnosis in patients with non-small cell lung cancer. Med Oncol 29: 3176-82, 2012.
18. Engan T and Hannisdal E: Blood analyses as prognostic factors in primary lung cancer. Acta Oncol 29: 151-154, 1990. (Pubitemid 20145276)
19. Cakar B, Karaoglanoglu M, Sayici Y, Gonullu DG and Yucel I: The prognostic value of thrombocytosis in newly diagnosed lung cancer patients: a retrospective analysis. J BUON 16: 677-81, 2011.